By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Gemin X Biotechnologies Inc. 

P.O. Box 477
Place du Parc
Montreal,  Quebec    Canada
Phone: 514-281-8989 Fax: 514-281-1065


SEARCH JOBS


Industry
Biotechnology






Company News
Gemin X Biotechnologies Inc. to Present at the 29th Annual Cowen Healthcare Conference 3/11/2009 9:42:57 AM
Senior Pharmaceutical Executive, Glenn J. Gormley, M.D., Ph.D., to Lead Gemin X Biotechnologies Inc. as President and CEO 6/10/2008 8:33:35 AM
Tripos Discovery Research Ltd. (TRPS), a Subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), Secures a Discovery Milestone Payment from Gemin X Biotechnologies Inc. 8/7/2007 11:17:55 AM
Gemin X Biotechnologies Inc. Announces Publication in Blood of Positive Preclinical Data of Lead Compound in Mantle Cell Lymphoma 5/15/2007 12:05:04 PM
Gemin X Biotechnologies Inc. Initiates a Phase 1 Trial with GMX1777 in Solid Tumors and Lymphomas 5/8/2007 12:37:32 PM
Gemin X Biotechnologies Inc. Presents Positive Preclinical Data of GX15-070 in Infant ALL at American Association for Cancer Research Meeting 4/18/2007 12:59:44 PM
Gemin X Biotechnologies Inc. Announces Publication of Preclinical Data of GX15-070 in Multiple Myeloma in Blood 3/7/2007 12:04:36 PM
Gemin X Biotechnologies Inc. Initiates Phase 1/2 Combination Trials With GX15-070 In Non-Small Cell Lung Cancer And Mantle Cell Lymphoma 1/31/2007 12:03:04 PM
Gemin X Biotechnologies Inc. To Present At The 25th Annual JPMorgan Healthcare Conference 12/21/2006 11:01:45 AM
Gemin X Biotechnologies Inc.'s Pan-Bcl-2 Antagonist GX15-070 Permits Rational Combination With Velcade In Mantle Cell Lymphoma 12/13/2006 10:33:26 AM
123
//-->